Kanaph CEO On Surviving The Biotech Funding 'Barley Hump'

Pursuing Platform, Pipeline, Modality Diversity

difficult financing
Korean Bioventures Have Less Capacity To Endure Financial Hardship • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from South Korea

More from Focus On Asia